Omid Farokhzad: From Tehran to the Edge of Nanomedicine

Alongside BIND, he contributed to the founding of Selecta Biosciences, a company focused on reducing harmful immune responses that often complicate therapeutic treatments. The company later merged with another biotechnology firm, reflecting the dynamic evolution of the biotech industry. Through these ventures, Farokhzad demonstrated his ability not only to advance scientific innovation but to build organizations capable of sustaining it.